A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD) (Me&MyCOPD)
A Real-World Assessment of a COPD Disease Management Support Service (Me & My COPD).
Sponsor: AstraZeneca
Listed as NCT02300090, this observational or N/A phase trial focuses on Chronic Obstructive Pulmonary Disease and remains completed. Sponsored by AstraZeneca, it has been updated 12 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Oct 2018 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Aug 2018 — Oct 2018 [monthly]
Active Not Recruiting
▶ Show 7 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jun 2017 — Sep 2017 [monthly]
Recruiting NA
-
Apr 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — Apr 2017 [monthly]
Recruiting NA
First recorded
Oct 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .